Canada has lost its measles elimination status after nearly three decades, following a year-long outbreak that the Pan American Health Organization (PAHO) confirmed on Monday. The setback also affects the Americas region, which now loses its measles-free designation.
According to PAHO Director Dr. Jarbas Barbosa, the loss is “reversible” but serves as a warning to strengthen public health efforts. Canada has reported over 5,000 measles cases across nine provinces and one northern territory, with under-vaccinated communities driving the prolonged transmission.
Health experts say the resurgence of measles highlights serious lapses in vaccination outreach and growing vaccine hesitancy since the COVID-19 pandemic. Dr. Isaac Bogoch, an infectious disease specialist at Toronto General Hospital, described the situation as “a wake-up call” for Canada to improve accessibility and trust in immunization programs.
To maintain herd immunity, a 95% vaccination rate is required, as the measles vaccine is 97% effective after two doses. However, declining vaccination rates have allowed the virus to spread more easily, posing severe risks to children and vulnerable populations.
The Public Health Agency of Canada stated that while the spread has slowed, the outbreak persisted for over 12 months. The agency pledged to boost vaccination coverage, strengthen surveillance systems, and improve data sharing nationwide.
In Alberta, one of the hardest-hit provinces, cases have dropped by over 90% from their peak, with vaccination rates up 50% since March. Despite these gains, experts warn that losing measles elimination status is “a step backward,” symbolizing a return to preventable disease risks.
Other countries in the Americas, including the United States, Mexico, and Brazil, are also facing outbreaks as global vaccination rates decline—a concerning trend that could reverse decades of public health progress.


Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Trump Orders Reduction in U.S.-South Korea Military Drills, Citing Kim Jong Un Ties
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Trump Grants Clemency to Jay-Z Associate Emory Jones
Trump Orders Major Overhaul of US Navy Shipbuilding
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Trump Imposes New US Tariffs on Drone Imports Over National Security Concerns
Guatemala Receives 2,300 Mexicans Deported From US
FAA to Pause Reagan National Airport Flights for Freedom 250 IndyCar Race
Google Changes EU Spam Policy Amid Antitrust Scrutiny
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Texas Republicans Turn Against AI Data Centers as Election Backlash Grows
Trump Administration Pauses Visa Appointments Worldwide
SEC Proposes ‘Regulation Crypto Assets’ Framework for Crypto Fundraising
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 



